Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.18 is 159% above its 5-year average of -0.31, near the high end of its 5-year range (-1.07–0.18).
324.03% above its 12-month average of 0.04.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 28 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:06:24.828Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.18
EARNINGS PER SHARE (EPS) AVG TTM
0.04
EARNINGS PER SHARE (EPS) AVG 3Y
-0.14
EARNINGS PER SHARE (EPS) AVG 5Y
-0.31
EARNINGS PER SHARE (EPS) AVG 10Y
0.17
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+324.03%
CURRENT VS 3Y AVG
+229.71%
CURRENT VS 5Y AVG
+158.85%
CURRENT VS 10Y AVG
+8.60%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cronos Group Inc.
Market Cap
$1.22B
Earnings Per Share (EPS)
0.18
TTM Avg
0.04
3Y Avg
-0.14
5Y Avg
-0.31
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.02
TTM Avg
-0.12
3Y Avg
-0.17
5Y Avg
-0.18
Market Cap
$1.22B
Earnings Per Share (EPS)
0.06
TTM Avg
-0.54
3Y Avg
-0.90
5Y Avg
-0.90
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.14
TTM Avg
0.06
3Y Avg
-0.09
5Y Avg
-0.17
Market Cap
$1.24B
Earnings Per Share (EPS)
-1.35
TTM Avg
-1.65
3Y Avg
-1.88
5Y Avg
-2.16
Market Cap
$1.27B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.20
3Y Avg
-3.20
5Y Avg
-3.20
Market Cap
$1.17B
Earnings Per Share (EPS)
-124.78
TTM Avg
-85.76
3Y Avg
-67.06
5Y Avg
-58.99
Market Cap
$1.15B
Earnings Per Share (EPS)
N/A
TTM Avg
-9.21
3Y Avg
-17.43
5Y Avg
-24.99
Market Cap
$1.14B
Earnings Per Share (EPS)
0.04
TTM Avg
0.06
3Y Avg
0.01
5Y Avg
-0.18
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.22B | 0.18 | 0.04 | -0.14 | -0.31 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.02 | -0.12 | -0.17 | -0.18 |
| Omada Health (OMDA)vs › | $1.22B | 0.06 | -0.54 | -0.90 | -0.90 |
| MannKind Corporation (MNKD)vs › | $1.22B | -0.14 | 0.06 | -0.09 | -0.17 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | -1.35 | -1.65 | -1.88 | -2.16 |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | -3.20 | -3.20 | -3.20 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | -124.78 | -85.76 | -67.06 | -58.99 |
| Nektar Therapeutics (NKTR)vs › | $1.15B | N/A | -9.21 | -17.43 | -24.99 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 0.04 | 0.06 | 0.01 | -0.18 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | -2.04 | -2.04 | -2.04 |
Trailing EPS (TTM)
$0.18
Forward EPS (Est.)
N/A
P/E Ratio
18.1
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.03 |
| 2024-12-31 | 0.11 |
| 2023-12-31 | -0.19 |
| 2022-12-31 | -0.45 |
| 2021-12-31 | -1.07 |
| 2020-12-31 | -0.21 |
| 2019-12-31 | 3.76 |
| 2018-12-31 | -0.11 |
| 2017-12-31 | 0.02 |
| 2016-12-31 | -0.01 |
| 2015-12-31 | 0.01 |
| 2014-12-31 | -0.13 |
| 2013-12-31 | -0.05 |
| 2013-03-31 | -0.07 |
